BOSTON, August 22, 2017 — OM1 has been recognized by CIOReview Magazine as one of the top 100 most promising big data solution providers in 2017. OM1 was nominated and ultimately selected following CIOReview’s annual comprehensive review process. CIOReview’s editorial team analyzed approximately 1,000 companies that provide big data solutions and are at the forefront[…]
Published August 9 – by HealthEconomics.com Dr. Patti Peeples, CEO of HealthEconomics.Com, sat down with Dr. Rich Gliklich, CEO of OM1, to discuss how big data analytics are changing the face of real world evidence (RWE). HealthEcoOM1logonomics.Com asked Dr. Gliklich to shares his views on major transformational changes in evidence development and how these will[…]
Published by PM360 – August 9, 2017 The growing power of payers in healthcare decision-making has put an increased emphasis on health economics and outcomes research (HEOR), as the data collected through that research is key to demonstrating the value of your drug. As HEOR teams have grown in importance, their roles have expanded to[…]
On this webinar, Dr. Richard Gliklich, CEO of OM1, discussed the evolving role of big data and cognitive computing in generating real-world evidence for cardiovascular and metabolic diseases. This session explored how innovative methodologies and technologies can be applied to support safety, value, and commercial strategies. Topics covered included: New real-world evidence methodologies and approaches[…]
By Richard Gliklich, CEO, OM1 – Published in FierceHealth Executive Report The term big data elicits many different responses from the healthcare community and skepticism runs high among many clinicians and hospital executives. While big data alone can’t transform care, it is rapidly becoming the cornerstone of a fundamental change in the way we practice[…]
